787 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Bought by Brighton Jones LLC

Brighton Jones LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 787 shares of the biotechnology company’s stock, valued at approximately $203,000.

Several other large investors also recently modified their holdings of the business. Sands Capital Management LLC grew its position in shares of Axon Enterprise by 31.1% in the 3rd quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after purchasing an additional 619,179 shares during the period. Westfield Capital Management Co. LP lifted its stake in Axon Enterprise by 184.3% in the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after buying an additional 451,350 shares in the last quarter. Polar Capital Holdings Plc boosted its holdings in shares of Axon Enterprise by 292.0% in the third quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock valued at $52,825,000 after buying an additional 197,746 shares during the period. Bank of New York Mellon Corp increased its position in shares of Axon Enterprise by 28.3% during the third quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock worth $144,546,000 after acquiring an additional 160,359 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $39,907,000. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on AXON shares. JPMorgan Chase & Co. upped their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. Barclays boosted their target price on Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a research note on Thursday, February 29th. StockNews.com cut shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Finally, Morgan Stanley boosted their price objective on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, April 26th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $323.09.

View Our Latest Stock Analysis on Axon Enterprise

Axon Enterprise Trading Up 0.6 %

Shares of NASDAQ:AXON opened at $318.55 on Friday. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The company has a market capitalization of $24.04 billion, a P/E ratio of 138.50 and a beta of 0.91. The company has a 50-day simple moving average of $308.83 and a 200 day simple moving average of $265.28.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. Sell-side analysts forecast that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.